Healthcare and Life Science
42 Technology and Addenbrooke’s Hospital develop AI innovation to improve newborn eye screening
42 Technology is helping Cambridge University Hospitals NHS Foundation Trust (CUH) to develop an advanced AI feature for a groundbreaking hand-held newborn eye screening device. ...
Milner Institute signs MOU with Yonsei University for joint research in quantum computing
The agreement is expected to serve as a critical foundation for activating international joint research, academic exchange and research collaboration in quantum fields, including quantum computing. ...
Milner Institute delivers Cambridge-Google AlphaFold Workshop
The workshop brought together leading academic researchers, industry experts and innovators to explore the fundamentals of AlphaFold – an artificial intelligence (AI) program developed by Google DeepMind to predict the 3D structure of proteins. ...
Strengthening human factors leadership to drive user-centred design innovation
At Team Consulting, we have been working at the forefront of human factors since 1999, helping our clients to create medical products that are not only regulatory compliant, but that delight end users. Achieving this balance requires a deep understanding of the medical device developmen...
CMR Surgical raises more than $200m to accelerate growth in US and globally
Global surgical robotics company CMR Surgical in Cambridge has closed a funding round of more than $200 million to underpin worldwide expansion – notably in the US.The haul has been raised through a combination of equity and debt capital to support the company’s ambitious growth plans.T...
Cambridge Innovation Capital co-leads $31M seed financing for TRIMTECH Therapeutics to advance neurodegenerative disease treatments
Cambridge Innovation Capital (CIC), a leading investor in life sciences and deep tech companies, today announces its role as a co-lead investor in TRIMTECH Therapeutics’ $31 million (£25 million) seed funding round. The financing round, which was oversubscribed, was also co-led by SV He...
Epitopea announces license and research collaboration agreement with MSD to identify cryptigenTM tumor-specific antigens
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, announces a license and research collaboration agreement with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to identify CryptigenTM tumor-specif...
Sphere Bio expands APAC distribution network to strengthen presence in region
Operational scale-up accelerates global growth strategy to increase regional access and technical supportCambridge, UK, 9th April 2025: Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, announces a significant ...
The 8Cs of smart business expansion: A simple framework for going big, the right way
By Gary Jennings, Innovation Director, The EpiCentre.
The role of AI and omnichannel strategies in healthcare marketing
Co-authored by Jose Maria (Chema) Guido Avila, SanofiThe pharmaceutical industry is at a pivotal moment. As the world grows more digital and patients become more informed, traditional marketing strategies are losing their effectiveness. Doctors are overwhelmed with information, and pati...